Simcere Pharmaceutical Group (HKSE:02096) Other Stockholders Equity : HK$4,021 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Simcere Pharmaceutical Group Other Stockholders Equity?

Simcere Pharmaceutical Group's Other Stockholders Equity for the quarter that ended in Jun. 2024 was HK$4,021 Mil.

Simcere Pharmaceutical Group's quarterly Other Stockholders Equity increased from Jun. 2023 (HK$1,193 Mil) to Dec. 2023 (HK$4,429 Mil) but then declined from Dec. 2023 (HK$4,429 Mil) to Jun. 2024 (HK$4,021 Mil).

Simcere Pharmaceutical Group's annual Other Stockholders Equity increased from Dec. 2021 (HK$1,019 Mil) to Dec. 2022 (HK$1,105 Mil) and increased from Dec. 2022 (HK$1,105 Mil) to Dec. 2023 (HK$4,429 Mil).

Simcere Pharmaceutical Group Other Stockholders Equity Historical Data

The historical data trend for Simcere Pharmaceutical Group's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simcere Pharmaceutical Group Other Stockholders Equity Chart

Simcere Pharmaceutical Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

1,647.15

2,725.21

1,018.95

1,104.80

4,428.64

Simcere Pharmaceutical Group Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Stockholders Equity	Get a 7-Day Free Trial								3,663.76	1,104.80	1,193.31	4,428.64	4,020.79

Simcere Pharmaceutical Group Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Simcere Pharmaceutical Group Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Simcere Pharmaceutical Group's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Simcere Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Simcere Pharmaceutical Group Ltd (HKSE:02096) » Definitions » Other Stockholders Equity

Traded in Other Exchanges

S2P:Germany

Address

No. 699-18, Xuanwu Road, Xuanwu District, Jiangsu, Nanjing, CHN, 210042

Website

https://www.simcere.com

Simcere Pharmaceutical Group Ltd is engaged in the R&D, production, and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases, and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.

Executives

Wang Xi	2305 Beneficiary of a trust
Ren Jinsheng	2202 Interest of your spouse
Right Wealth Holdings Limited	2501 Other
Wang Xi	2501 Other
Simcere Investments Group Limited	2501 Other
Excel Investments Group Limited	2501 Other
Simcere Pharmaceutical Holding Limited	2501 Other
Simcere Holding Limited	2501 Other
Artking Global Limited	2501 Other
Ren Zhen	2501 Other
Ren Yong	2501 Other
Ren Weidong	2501 Other
Peng Suqin	2501 Other
P&h Holdings Group Ltd.	2501 Other
Li Shimeng	2501 Other

Simcere Pharmaceutical Group Headlines

No Headlines